Academic Journal

Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer

التفاصيل البيبلوغرافية
العنوان: Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer
المؤلفون: Leighl N. B., Karaseva N., Nakagawa K., Cho B. -C., Gray J. E., Hovey T., Walding A., Ryden A., Novello S.
المساهمون: Leighl N.B., Karaseva N., Nakagawa K., Cho B.-C., Gray J.E., Hovey T., Walding A., Ryden A., Novello S.
سنة النشر: 2019
المجموعة: Università degli studi di Torino: AperTo (Archivio Istituzionale ad Accesso Aperto)
مصطلحات موضوعية: EORTC QLQ-C30, EORTC QLQ-LC13, Non-small-cell lung cancer, Osimertinib, Patient-reported outcomes
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/31838405; info:eu-repo/semantics/altIdentifier/wos/WOS:000505199600007; volume:125; firstpage:49; lastpage:57; numberofpages:9; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/2318/1720822; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85076114162; http://www.journals.elsevier.com/european-journal-of-cancer/
DOI: 10.1016/j.ejca.2019.11.006
الاتاحة: http://hdl.handle.net/2318/1720822
https://doi.org/10.1016/j.ejca.2019.11.006
http://www.journals.elsevier.com/european-journal-of-cancer/
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.3D484D5C
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.ejca.2019.11.006